在初级PCI期间无反流的冠心血管活性疗法:随机试验的网络元分析
Federico Oliveri1, Lorenzo Tua2, Luca Raone2
1Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
JACC. Advances
|February 25, 2026
概括
冠内维拉帕米尔和上腺素改善冠状动脉血流,经皮肤冠状动脉干预无反流现象后. 这些药物显示出比对照药物更好的结果,但没有减少主要心血管不良事件或死亡率.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 无回流现象是初级穿皮冠状动脉干预的常见并发症.
- 它与患者的不良结果有关,但有效的药理疗法有限.
研究的目的:
- 为了比较常用的冠心内药物的疗效,用于治疗无反流现象.
- 评估冠内腺素,上腺素,酸和维拉帕米尔.
主要方法:
- 随机对照试验的系统审查和频率网络元分析.
- 包括13项研究,包括1674名接受初级穿皮冠状动脉干预的患者.
- 主要终点:恢复TIMI流量等级3;次要终点:ST段分辨率,MACE和死亡率.
主要成果:
- 与对照组相比,上腺素和维拉帕米尔显著增加了实现TIMI流量等级3的几率.
- 上腺素,维拉帕米尔和腺改善了ST段的分辨率.
- 对于任何药物,都没有观察到主要心血管不良事件或死亡率的显著减少.
结论:
- 冠状动脉内维拉帕米尔和上腺素在没有反流的情况下有效改善冠状动脉血流.
- 需要进一步的研究来确定临床实践的最佳药物.
相关概念视频
Coronary Artery Disease V: Interprofessional Care
343
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
343
Acute Coronary Syndrome III: Diagnostic Studies
338
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
338
Acute Coronary Syndrome IV: Interprofessional Care
347
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
347
Peripheral Artery Disease III: Interprofessional Care
433
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
433
Acute Coronary Syndrome I: Introduction
1.2K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.2K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
1.6K
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.6K


